Effective Use of In Vitro Skin Penetration Studies in Topical Formulation Development.  AGAH (Association for Applied Human Pharmacology) Dermatological Product Development: An International Workshop on Strategy and Regulatory Requirements from Formulation through Clinical Development.  May 27-28, 2010 in Hamburg, Germany

 

 Topical Formulation Development and Screening. DOW / Pharmaceutical Technology Webcast to over 400 registrants. April 28, 2010

 Formulation Optimization – tomorrow’s solution to acne management. Interface Regional Meeting – Coria Laboratories. April 16-17, 2010 in Dallas, TX

 

 Formulation Optimization – tomorrow’s solution to acne management. Interface Regional Meeting – Coria Laboratories. March 19-20, 2010 in New York, NY

 

 Formulation Screening with In Vitro Penetration Studies. DOW Workshop “Topical Dermatological Product Development in the USA”. June 4, 2009 in East Brunswick, NJ

 

 An In Vitro Model using Newborn Bovine Eyes to Assess Cornea and Sclera Permeation.  ARVO Annual Meeting (The Association for Research in Vision and Opthalmology). April 30 – May 4, 2006 in Fort Lauderdale, FL

 

 Stratum Corneum, Epidermis and Dermis Barrier Function: Implications in the Development of Topical Products Containing Large Molecular Weight Drugs. Perspectives in Percutaneous Penetration, Tenth International Conference. April 18-22, 2006 in La Grande-Motte, FR

 

 Stratum Corneum, Epidermis and Dermis Barrier Function: Implications in the Development of Topical Products Containing Large Molecular Weight Drugs. AAPS National Biotechnology Conference. June 5-8, 2005 in San Francisco, CA

 

 Unique Methods for Enhancing Drug Penetration Into and Through the Skin. American Association of Pharmaceutical Scientists Annual Meeting. Nov. 8, 2004 in Baltimore, Maryland.

 

 Case Studies and Dermatologic Applications of Macromolecules. Session Chair. Silverado Biotech Symposium. Sept. 13-14, 2004 in Napa, CA.

 

 Significance of Formulation Composition on Clindamycin Release from Gels and Corresponding Clinical Utility.  American Academy of Dermatology (AAPS) Annual Meeting. Mar. 23, 2003 in San Francisco, CA.

 

 In Vitro Release of Clindamycin Phosphate: Effect of Viscosity. American Association of Pharmaceutical Scientists Annual Meeting. Nov. 14, 2002 in Toronto, Canada.

 

 Skin Irritation Reduction – Is it Possible?  Perspectives in Percutaneous Penetration April 25 – 29, 2000 in La Grande Motte, Languedoc, France.

 

 Topical Retinoid Therapy – Recent Advances. Perspectives in Percutaneous Penetration April 25 – 29, 2000 in La Grande Motte, Languedoc, France.

 

 Topical Retinoid and Antifungal Therapy. Bertek Sales Meeting. April 30, 1999 in Miami, FL.

 

Comparison of Butenafine, Terbinafine and Azole Clinical Efficacy in the Treatment of Tinea Infections. International Investigative Dermatology Meeting. May 7-10, 1998 in Cologne, Germany.

 

 Polyolprepolymers: A New Topical Delivery Technology to Improve Efficacy. Society of Cosmetic Chemists, Golden Gate Chapter. Jan. 29, 1998 in Berkeley, CA.

 

 Chairperson for ‘Other Delivery Agents’ session at IBC’s International Conference on Delivery Technologies for Cosmetic Ingredients.  And presented “Polyolprepolymers: A New Topical Delivery Technology to Improve Efficacy”. May 15 & 16, 1997 in Philadelphia, PA.

 

 Polyolprepolymers:  Properties and Uses in Cosmetic Products. Barnet Sales Meetings. March 16-18, 1997 in Beverly Hills, CA.

 

 An Unexpected Finding in the Percutaneous Absorption Observed Between Haired and Hairless Guinea Pigs.  American Association of Pharmaceutical Scientists (AAPS) Annual Meeting. Oct. 27-31, 1996 in Seattle, WA.

 

 Polyolprepolymers:  A Cutaneous Retention and Deposition Technology. Advances in Skin Biology, 10th Annual meeting. Rutgers University.  Jun 24-27, 1996 in Rutgers, NJ.